Q4 drug pricing brings mostly mild changes, with a few big gainers, losers

Why This Topic Matters

Drug payment updates can affect reimbursement, budgeting, and charge capture across a wide range of specialties. Understanding which therapies moved materially, which stayed stable, and what payment methodology changes are being considered helps organizations anticipate operational and financial impact.

Article Sections

1. Drug price changes in the quarterly ASP update

   Summarizes the overall pattern of the latest Medicare drug price update and highlights broad movement across the schedule. Includes discussion of notable gainers and losers and how the update compares with prior quarters and year-over-year trends.

2. Changes coming to drug payments

   Describes policy discussion around Medicare’s drug reimbursement methodology and references CMS and GAO activity. Covers the broader context for possible future changes to drug payment calculations.

3. Top ASP drug price increases for Q4 2016

   Presents a table of the largest quarterly increase examples in the ASP update. Focuses on payment-limit movements for selected HCPCS drug codes.

4. Top ASP drug price decreases for Q4 2016

   Presents a table of the largest quarterly decrease examples in the ASP update. Focuses on payment-limit movements for selected HCPCS drug codes.